Advertisement
Screener

BIOGEN INC. (BIIB) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

BIOGEN INC. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • BIOGEN INC. return tang equity for the quarter ending 2026-03-31 was 27.95%, a 48.54% decline year-over-year.
  • BIOGEN INC. return tang equity for the quarter ending 2025-12-31 was 29.48%, a 57.51% decline year-over-year.
  • BIOGEN INC. return tang equity for the quarter ending 2025-09-30 was 38.40%, a 54.48% decline year-over-year.
  • BIOGEN INC. return tang equity for the quarter ending 2025-06-30 was 44.02%, a 37.96% decline year-over-year.
  • BIOGEN INC. return tang equity for fiscal 2025 was 29.48%, a 57.51% decline from fiscal 2024.
  • BIOGEN INC. return tang equity for fiscal 2024 was 69.37%, a 62.58% increase from fiscal 2023.
  • BIOGEN INC. return tang equity for fiscal 2023 was 42.67%, a 18.03% decline from fiscal 2022.
  • BIOGEN INC. return tang equity for fiscal 2022 was 52.05%, a 6.18% increase from fiscal 2021.
Available history
2007-12-31 to 2026-03-31
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-03-3127.95%$1.37B$4.91B
2025-12-3129.48%$1.29B$4.39B
2025-09-3038.40%$1.61B$4.19B
2025-06-3044.02%$1.53B$3.48B
2025-03-3154.31%$1.48B$2.72B
2024-12-3169.37%$1.63B$2.35B
2024-09-3084.37%$1.62B$1.91B
2024-06-3070.96%$1.16B$1.63B
2024-03-31128.92%$1.17B$904.9M
2023-12-3142.67%$1.16B$2.72B
2023-09-3024.83%$1.46B$5.89B
2023-06-3038.50%$2.66B$6.92B
2023-03-3150.10%$3.13B$6.25B
2022-12-3152.05%$3.05B$5.85B
2022-09-3057.28%$2.86B$5B
2022-06-3050.36%$2.06B$4.09B
2022-03-3142.17%$1.45B$3.44B
2021-12-3149.03%$1.56B$3.17B
2021-09-3053.98%$1.55B$2.86B
2021-06-3060.07%$1.92B$3.19B
2021-03-31113.98%$3.01B$2.64B
2020-12-31150.05%$4B$2.67B
2020-09-30204.04%$5.08B$2.49B
2020-06-30194.94%$5.93B$3.04B
2020-03-31137.13%$5.88B$4.29B
2019-12-31115.84%$5.89B$5.08B
2019-09-3095.23%$5.4B$5.67B
2019-06-30114.60%$5.29B$4.62B
2019-03-3183.30%$4.67B$5.6B
2018-12-3193.37%$4.43B$4.75B
2018-09-3038.30%$3.19B$8.32B
2018-06-3041.90%$2.97B$7.08B
2018-03-3132.47%$2.96B$9.13B
2017-12-3131.88%$2.54B$7.97B
2017-09-3039.97%$3.49B$8.72B
2017-06-3042.74%$3.29B$7.7B
2017-03-3144.29%$3.48B$7.86B
2016-12-3143.77%$3.7B$8.46B
2016-09-3044.68%$3.89B$8.7B
2016-06-3046.35%$3.82B$8.24B
2016-03-3149.87%$3.7B$7.41B
2015-12-3152.85%$3.55B$6.71B
2015-09-3044.11%$3.6B$8.16B
2015-06-3033.50%$3.49B$10.42B
2015-03-3133.38%$3.28B$9.82B
2014-12-3132.42%$2.93B$9.05B
2014-09-3028.22%$2.51B$8.89B
2014-06-3026.09%$2.14B$8.2B
2014-03-3124.22%$1.92B$7.91B
2013-12-3125.21%$1.86B$7.39B
2013-09-3024.54%$1.7B$6.91B
2013-06-3024.03%$1.61B$6.69B
2013-03-3124.54%$1.5B$6.13B
2012-12-3123.95%$1.38B$5.76B
2012-09-3025.44%$1.39B$5.46B
2012-06-3026.45%$1.34B$5.07B
2012-03-3124.30%$1.24B$5.12B
2011-12-3123.38%$1.23B$5.28B
2011-09-3032.20%$1.17B$3.65B
2011-06-3031.03%$1.08B$3.47B
2011-03-3135.04%$1.08B$3.09B
2010-12-3135.10%$1.01B$2.86B
2010-09-3042.96%$1.07B$2.49B
2010-06-3041.55%$1.09B$2.63B
2010-03-3119.61%$943.59M$4.81B
2009-12-3118.94%$970.13M$5.12B
2009-09-3015.96%$871.15M$5.46B

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-3129.48%$1.29B$4.39B
2024-12-3169.37%$1.63B$2.35B
2023-12-3142.67%$1.16B$2.72B
2022-12-3152.05%$3.05B$5.85B
2021-12-3149.03%$1.56B$3.17B
2020-12-31150.05%$4B$2.67B
2019-12-31115.84%$5.89B$5.08B
2018-12-3193.37%$4.43B$4.75B
2017-12-3131.88%$2.54B$7.97B
2016-12-3143.77%$3.7B$8.46B
2015-12-3152.85%$3.55B$6.71B
2014-12-3132.42%$2.93B$9.05B
2013-12-3125.21%$1.86B$7.39B
2012-12-3123.95%$1.38B$5.76B
2011-12-3123.38%$1.23B$5.28B
2010-12-3123.36%$1.01B$4.3B
2009-12-3118.94%$970.13M$5.12B
2008-12-3116.68%$783.17M$4.7B
2007-12-3111.49%$638.17M$5.55B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29